Publicacións en colaboración con investigadores/as de Gustave Roussy Cancer Campus (25)

2023

  1. Fibroblasts generate topographical cues that steer cancer cell migration

    Science advances, Vol. 9, Núm. 33, pp. eade2120

2022

  1. Breast cancer risks associated with missense variants in breast cancer susceptibility genes

    Genome Medicine, Vol. 14, Núm. 1

  2. Tackling Thyroid Cancer in Europe—The Challenges and Opportunities

    Healthcare (Switzerland), Vol. 10, Núm. 9

2021

  1. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

    Nature Communications, Vol. 12, Núm. 1

  2. Immunotherapy-induced isolated ACTH deficiency in cancer therapy

    Endocrine-related cancer, Vol. 28, Núm. 12, pp. 783-792

  3. Report of the fifth meeting of the European Consortium 'Care for CMMRD' (C4CMMRD), Leiden, The Netherlands, July 6th 2019

    Familial Cancer, Vol. 20, Núm. 1, pp. 67-73

2020

  1. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

    Nature Genetics, Vol. 52, Núm. 1, pp. 56-73

2019

  1. EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer

    European Journal of Cancer, Vol. 117, pp. 60-68

  2. Novel common genetic susceptibility loci for colorectal cancer

    Journal of the National Cancer Institute, Vol. 111, Núm. 2, pp. 146-157

  3. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

    npj Breast Cancer, Vol. 5, Núm. 1

2018

  1. Circulating tumor cells in breast cancer patients treated by neoadjuvant chemotherapy: A Meta-analysis

    Journal of the National Cancer Institute, Vol. 110, Núm. 6, pp. 560-567

2017

  1. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

    Nature Genetics, Vol. 49, Núm. 12, pp. 1767-1778

2016

  1. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up

    Annals of Oncology, Vol. 27, Núm. 1, pp. 16-41

  2. Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of european ancestry

    Human Molecular Genetics, Vol. 25, Núm. 6, pp. 1203-1214

2015

  1. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

    Journal of the National Cancer Institute, Vol. 107, Núm. 12

  2. Azacitidine frontline therapy for unfit acute myeloid leukemia patients: Clinical use and outcome prediction

    Leukemia Research, Vol. 39, Núm. 3, pp. 296-306

  3. Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating Agents

    Gastroenterology, Vol. 149, Núm. 4, pp. 1017-1029.e3

2014

  1. Alcohol consumption and survival after a breast cancer diagnosis: A literature-based meta-analysis and collaborative analysis of data for 29,239 cases

    Cancer Epidemiology Biomarkers and Prevention, Vol. 23, Núm. 6, pp. 934-945

  2. Diagnostic criteria for constitutional mismatch repair deficiency syndrome: Suggestions of the European consortium 'Care for CMMRD' (C4CMMRD)

    Journal of Medical Genetics, Vol. 51, Núm. 6, pp. 355-365

  3. Genome-wide association study identifies multiple loci associated with bladder cancer risk

    Human Molecular Genetics, Vol. 23, Núm. 5